EMERGENT BIOSOLUTIONS ($EBS) posted quarterly earnings results on Monday, March 3rd. The company reported earnings of $0.05 per share, beating estimates of -$0.50 by ...

Emergent Biosolutions (EBS) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.35 per share. This compares to loss of $0.77 per share a year ago.

Despite a dip in Q4 revenue, Emergent BioSolutions Inc (EBS) showcases significant profitability improvements and strategic positioning for future growth. EBS) on Monday reported a loss of $31.3 ...

Good day, and thank you for standing by. Welcome to Emergent BioSolutions Inc. Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the ...

Jazz Pharmaceuticals acquires Chimerix (CMRX) for $935M, adding ONC201, a promising brain cancer drug. Find out why I believe ...

ADV for interest rate complex and U.S. Treasury markets Record monthly international ADV of 9.5 million contracts Record February ADV in agricultural ...

Intel Corp. $20.90 0.09 0.43% ...

SEC Filings provided by EDGAR Online, Inc.

Do you aspire to work in business and transform organisations for the better? Choose from a diverse range of undergraduate degree courses tailored to your aspirations. We offer a robust business ...